These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19551365)

  • 1. High-throughput screening of the cyclic AMP-dependent protein kinase (PKA) using the caliper microfluidic platform.
    Blackwell LJ; Birkos S; Hallam R; Van De Carr G; Arroway J; Suto CM; Janzen WP
    Methods Mol Biol; 2009; 565():225-37. PubMed ID: 19551365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reading dynamic kinase activity in living cells for high-throughput screening.
    Allen MD; DiPilato LM; Rahdar M; Ren YR; Chong C; Liu JO; Zhang J
    ACS Chem Biol; 2006 Jul; 1(6):371-6. PubMed ID: 17163774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
    Perrin D; Frémaux C; Scheer A
    J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection.
    He Y; Yeung ES
    Electrophoresis; 2003 Jan; 24(1-2):101-8. PubMed ID: 12652579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro- and nanofluidic systems for high-throughput biological screening.
    Hong J; Edel JB; deMello AJ
    Drug Discov Today; 2009 Feb; 14(3-4):134-46. PubMed ID: 18983933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A generic high-throughput screening assay for kinases: protein kinase a as an example.
    Mallari R; Swearingen E; Liu W; Ow A; Young SW; Huang SG
    J Biomol Screen; 2003 Apr; 8(2):198-204. PubMed ID: 12844441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening for kinase inhibitors.
    von Ahsen O; Bömer U
    Chembiochem; 2005 Mar; 6(3):481-90. PubMed ID: 15742384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric nanoparticles for protein kinase activity.
    Kim JH; Lee S; Kim K; Jeon H; Park RW; Kim IS; Choi K; Kwon IC
    Chem Commun (Camb); 2007 Apr; (13):1346-8. PubMed ID: 17377677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process validation and screen reproducibility in high-throughput screening.
    Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
    J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fission yeast-based high-throughput screens for PKA pathway inhibitors and activators.
    de Medeiros AS; Kwak G; Vanderhooft J; Rivera S; Gottlieb R; Hoffman CS
    Methods Mol Biol; 2015; 1263():77-91. PubMed ID: 25618337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a microplate-based, electrophoretic fluorescent protein kinase a assay: comparison with filter-binding and fluorescence polarization assay formats.
    Miick SM; Jalali S; Dwyer BP; Havens J; Thomas D; Jimenez MA; Simpson MT; Zile B; Huss KL; Campbell RM
    J Biomol Screen; 2005 Jun; 10(4):329-38. PubMed ID: 15964934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of on-chip and off-chip microfluidic kinase assay formats.
    Dunne J; Reardon H; Trinh V; Li E; Farinas J
    Assay Drug Dev Technol; 2004 Apr; 2(2):121-9. PubMed ID: 15165508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
    Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
    Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinase-focused compound collection: compilation and screening strategy.
    Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
    Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the miniaturization of GPCR-based live-cell screening assays.
    Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
    Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.